Wound healing
The biological process of tissue repair following injury, involving inflammation, proliferation, and remodeling phases. BPC-157, TB-500, and GHK-Cu accelerate various stages of wound healing in preclinical studies.
Frequently Asked Questions
What is Wound healing?
Why is Wound healing important in peptide research?
Related Terms
The formation of new blood vessels from existing vasculature. A key mechanism by which BPC-157 promotes tissue healing, restoring blood supply to injured areas to accelerate repair.
InflammationThe body’s immune response to injury, infection, or irritation. Acute inflammation is protective; chronic inflammation drives disease. Many peptides (BPC-157, KPV, LL-37, Thymosin Alpha-1) modulate inflammatory pathways.
FibrosisThe excessive formation of fibrous connective tissue in an organ, impairing its function. Can affect the liver (cirrhosis), lungs (pulmonary fibrosis), or any injured tissue. Anti-fibrotic peptide research is active.
ActinA globular protein that forms microfilaments in the cytoskeleton. Thymosin Beta-4 sequesters actin monomers and regulates actin polymerization, which is essential for cell migration and wound healing.
Related Peptide Profiles
Body Protection Compound-157, a synthetic pentadecapeptide derived from human gastric juice studied for tissue repair, gut healing, and anti-inflammatory effects.
TB-500A synthetic version of Thymosin Beta-4, a 43-amino acid peptide that promotes healing through actin upregulation, angiogenesis, and inflammation reduction.
GHK-CuA naturally occurring copper-binding tripeptide that stimulates collagen synthesis, modulates over 4,000 genes, and declines with age.